METSYSTEM has a unique technology that can predict cancer metastasis and determine the best chemotherapy to treat it preventively.
METSYSTEM has raised $1.4M in total funding. The most recent round was Convertible Note. The last funding was announced in March 2025.
METSYSTEM's investors include BioInnovation Institute, BioInnovation Institute Venture Lab.
METSYSTEM is headquartered in Copenhagen, Denmark.
METSYSTEM has a unique technology that can predict cancer metastasis and determine the best chemotherapy to treat it preventively.
METSYSTEM is at the Convertible Note stage.
Free to use in articles, research, and reference works. Stable URL — will not change. Data on this page last updated .
"METSYSTEM — Funding & Investors." VCBacked, March 7, 2025, https://www.vcbacked.co/company/metsystem. Accessed September 30, 2026.
VCBacked. (2025). METSYSTEM — Funding & Investors. Retrieved September 30, 2026, from https://www.vcbacked.co/company/metsystem
{{cite web |title=METSYSTEM — Funding & Investors |url=https://www.vcbacked.co/company/metsystem |website=VCBacked |access-date=September 30, 2026}}Profile data sourced and verified per the VCbacked methodology · Last funding round dated